EPO and periodontitis: In summary, our study suggests that the utilization of the EPO-FK506-CS/β-GP/GA hydrogel system exhibits potential in suppressing periodontal inflammation, facilitating periodontal tissue restoration and regeneration, and holds promising prospects for local drug therapy in periodontitis.